Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron (June 27, 2017)
Cyclacel Pharmaceuticals, Inc. and Paul McBarron have agreed to extend their existing agreement, originally dated January 2, 2014, through December 31, 2017. This document serves as written confirmation of the extension, with both parties acknowledging and agreeing to the new end date by signing the letter.
Exhibit 10.2
CYCLACEL PHARMACEUTICALS, INC.
200 Connell Drive, Suite 1500
Berkeley Heights, NJ 07922
June 27, 2017
Mr. Paul McBarron
c/o Cyclacel Pharmaceuticals, Inc.
200 Connell Drive, Suite 1500
Berkeley Heights, NJ 07922
Dear Mr. McBarron:
Reference is made to the agreement between us (the “Agreement”) made as of January 2, 2014. This will confirm our agreement to extend the Agreement through the period ended December 31, 2017. Please confirm your agreement to the foregoing by signing below in the space provided.
| Sincerely, | ||
| CYCLACEL PHARMACEUTICALS, INC. | ||
| By: | /s/ Spiro Rombotis | |
| Name: | Spiro Rombotis | |
| Title: | President & CEO | |
| ACKNOWLEDGED AND AGREED: | |
| /s/ Paul McBarron | |
| Paul McBarron |
